What are the treatment options for polycystic ovary syndrome (PCOS) in a reproductive‑age woman?

Treatment of Polycystic Ovary Syndrome (PCOS)

All women with PCOS should begin treatment with lifestyle modification—specifically weight loss of at least 5% of initial body weight through regular exercise and caloric restriction—as this foundational intervention improves both metabolic and reproductive outcomes regardless of fertility goals. 1

Initial Assessment and Screening

Before initiating treatment, perform the following evaluations:

• Metabolic screening: Fasting glucose followed by 2-hour glucose tolerance test with 75-gram glucose load to screen for type 2 diabetes and glucose intolerance 1
• Lipid assessment: Complete fasting lipoprotein profile including total cholesterol, LDL, HDL, and triglycerides 1
• Anthropometric measurements: Calculate BMI and waist-hip ratio 1
• Endocrine evaluation: TSH, prolactin, and total/free testosterone levels to exclude other causes of hyperandrogenism 1

Treatment Algorithm Based on Primary Goals

For Women NOT Seeking Pregnancy

Menstrual Regulation and Endometrial Protection

Combined oral contraceptive pills (OCPs) are the first-line pharmacologic treatment for women with PCOS not attempting conception, providing multiple benefits: suppression of ovarian androgen secretion, increased sex hormone-binding globulin, menstrual cycle regulation, and reduction in endometrial cancer risk 1.

• OCPs cause increases in triglycerides and HDL cholesterol, but no evidence suggests increased cardiovascular events in PCOS patients compared to the general population 1
• For women with contraindications to OCPs, use medroxyprogesterone acetate (depot or intermittent oral) to suppress androgens and provide endometrial protection, though optimal dosing and frequency remain undefined 1

Metabolic Management

Insulin-sensitizing agents improve metabolic parameters and may reduce cardiovascular risk factors, though they are not FDA-approved specifically for PCOS treatment 1:

• Metformin (biguanide): Improves or maintains glucose tolerance over time, tends to decrease weight, and may positively impact diabetes and cardiovascular disease risk factors 1
• Thiazolidinediones (pioglitazone, rosiglitazone): Improve insulin sensitivity but tend to increase weight; troglitazone was removed from market due to hepatotoxicity 1

Important caveat: The role of insulin-sensitizing agents in primary or secondary prevention of cardiovascular disease in PCOS remains unknown 1

Hyperandrogenism and Hirsutism

Treatment is often palliative rather than curative 1:

• First-line: OCPs for androgen suppression 1
• Second-line for severe cases: Combine OCPs with antiandrogen drugs (spironolactone, flutamide, or finasteride), though the optimal agent is not established 1
• FDA-approved topical therapy: Eflornithine hydrochloride cream is the only FDA-labeled treatment specifically for hirsutism 1
• Mechanical methods: Plucking, shaving, waxing, electrolysis, or laser vaporization require multiple treatments and should be combined with medical androgen suppression 1

For Women Seeking Pregnancy

First-Line Ovulation Induction

Start with weight control and regular exercise, then proceed to clomiphene citrate as first-line pharmacologic therapy based on strong evidence of effectiveness: approximately 80% of PCOS women ovulate with clomiphene, and 50% of those who ovulate conceive 1.

Recent evidence suggests letrozole may be an alternative to clomiphene citrate for ovulation induction 2.

Second-Line Options for Clomiphene Failure

When clomiphene citrate fails, consider these approaches 2:

• Low-dose gonadotropin therapy (preferred over high-dose): Induces higher rates of monofollicular development with lower risk of ovarian hyperstimulation syndrome 1
• Adding metformin to clomiphene 2
• Laparoscopic ovarian drilling: May be used in select cases, though benefits remain undetermined by ACOG; transvaginal hydrolaparoscopy is emerging as an option 1, 3

Critical safety note: While metformin and thiazolidinediones improve ovulation frequency, their effects on early pregnancy are not fully known; metformin appears safe but documentation is limited 1

Third-Line Treatment

In vitro fertilization (IVF) is reserved for treatment failures; use antagonist-based "short" protocols preferentially as they carry lower risk of ovarian hyperstimulation syndrome compared to long protocols 2.

Lifestyle Modification Details

Weight loss of as little as 5% of initial body weight improves metabolic and reproductive abnormalities, ovulation rates, and pregnancy rates 1.

• Exercise programs likely provide positive effects even without weight loss 1
• Avoid high-protein diets: Limited evidence supports their benefit, with concerns about adverse effects on renal function and lipids 1
• Before initiating drug therapy: Always attempt regular exercise and weight control measures first 1

Common Pitfalls to Avoid

• Do not use polycystic ovarian morphology on ultrasound or anti-Müllerian hormone levels for diagnosis in adolescents 4
• Do not use metformin solely for infertility in absence of metabolic abnormalities 3
• Do not use high-dose gonadotropin protocols when low-dose options are available due to increased hyperstimulation risk 1
• Screen all PCOS patients for dyslipidemia and diabetes regardless of symptoms, as cardiovascular disease is now considered a risk-enhancing factor in PCOS 1, 5
• Address mental health: Depression and anxiety are highly prevalent in PCOS and may be linked to metabolic dysfunction 5